drugset / Trial / NCT01031186
First Time in Human Study
RandomizedCrossoverSingle-blindTreatment
Summary
This study will evaluate the safety, tolerability, and pharmacokinetics of GSK356278 in male volunteers
Timeline
- Start
- 2009-11-23
- Primary completion
- 2010-04-07
- Completion
- 2010-04-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK356278 | Small molecule | 0.5 mg | — |
| Subject | GSK356278 | Small molecule | 1.5 mg | — |
| Subject | GSK356278 | Small molecule | 4 mg | — |
| Subject | GSK356278 | Small molecule | 8 mg | — |
| Subject | GSK356278 | Small molecule | 16 mg | — |
| Subject | GSK356278 | Small molecule | 30 mg | — |
| Subject | GSK356278 | Small molecule | 50 mg | — |